You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 4, April 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Monocyte Tumor Necrosis Factor Receptor Levels as a Predictor of Risk in Human Sepsis

Steve E. Calvano, PhD; Tom van der Poll, MD; Susette M. Coyle, RN; Philip S. Barie, MD; Lyle L. Moldawer, PhD; Stephen F. Lowry, MD

Arch Surg. 1996;131(4):434-437.


Abstract

Objective
To assess peripheral blood monocyte tumor necrosis factor receptor (TNFR) levels and plasma soluble tumor necrosis factor receptor (sTNFR) concentrations in critically ill patients with sepsis syndrome.

Design
Prospective, descriptive cohort study with no interventions.

Setting
Surgical intensive care unit of a tertiary-care hospital associated with a university medical school.

Patients
Twenty-one patients with a documented source of infection who met currently accepted criteria for sepsis syndrome/septic shock.

Main Outcome Measures
Plasma sTNFR p55 and p75 values were quantified by enzyme-linked immunosorbent assay, and monocyte TNFR levels were assessed by fluorescence flow cytometry after the monocytes were stained with biotinylated human recombinant TNF-{alpha} and streptavidin-phycoerythrin.

Results
Compared with healthy controls, plasma sTNFR p55 and p75 values were significantly higher (P<.01) in both surviving and nonsurviving patients with sepsis; in nonsurviving patients with sepsis, however, only sTNFR p55 values were significantly (P<.05) higher than in surviving patients with sepsis. By contrast, monocytes from the nonsurviving patients with sepsis manifested a significant (P<.01) and sustained (up to 4 days) decrease in cell surface TNFR values compared with either the normal controls or the surviving patients with sepsis.

Conclusions
Assessment of monocyte surface TNFR values may provide a rapid prognostic indicator for patients with sepsis who are at increased risk of death.

(Arch Surg. 1996;131:434-437)



Author Affiliations

From the Department of Surgery, Cornell University Medical College, New York, NY. Dr Moldawer is now with the Department of Surgery, University of Florida College of Medicine, Gainesville.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mediators or Markers of Injury, Inflammation, and Infection (Harbingers of Doom or Predictors of Disaster) and Biologic Puzzles or Ambiguities
Baue
Arch Surg 2007;142:89-93.
FULL TEXT  

Neutrophil-Related Inflammatory Mediators in Septic Acute Respiratory Distress Syndrome
Kinoshita et al.
J Intensive Care Med 2002;17:308-316.
ABSTRACT  

The Influence of Human Endotoxemia on CD95-Induced Apoptosis
Lin et al.
Arch Surg 1998;133:1322-1327.
ABSTRACT | FULL TEXT  

Multivariate Analysis of 9 Disease-Associated Variables for Outcome Prediction in Patients With Sepsis
Calvano et al.
Arch Surg 1998;133:1347-1350.
ABSTRACT | FULL TEXT  

Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation
Guirao et al.
Am. J. Physiol. Endocrinol. Metab. 1997;273:E1203-E1208.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.